News

Filter by:
By year:
Reset
  • Press Release
  • Other

AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic
  • Publication
  • Usher 1B

Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B

  • Press Release
  • Other

AAVantgarde Bio appoints Dr. Natalia Misciattelli as Chief Executive Officer
  • Press Release
  • Other

AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
  • Press Release
  • Other

AAVantgarde appoints Ram Palanki as Chairman of its Board of Directors
  • Publication
  • Stargardt

Inclusion of a degron reduces levels of undesired inteins after AAV-mediated protein trans-splicing in the retina

  • Press Release

Sofinnova Partners announces three new investments from its fund dedicated to Italian scientific research
  • Publication
  • Stargardt

Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina

  • Publication
  • Other

Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors

  • Publication
  • Other

Effective delivery of large genes to the retina by dual AAV vectors